| Date | Title | Description |
| 23.06.2025 | New €9 Million Biotech Fund to Back 30 Startups Solving Planetary Health Challenges | Biotope Ventures, a Belgium-based early-stage investor, has announced the successful first close of €5 million for its second fund, Biotope Ventures 2. The fund is targeting a total of €9 million, with an additional €4 million expected to b... |
| 17.06.2025 | Biotope Ventures 2: A New Dawn for Biotech Investment in Belgium | In the heart of Belgium, a financial seed is sprouting. Biotope Ventures 2 has officially launched, securing €5 million in its first close. This is just the beginning. The fund aims to reach a target of €9 million over the next 18 months. W... |
| 16.06.2025 | Belgian early-stage investor biotope raises €5 million to support up to 30 international BioTech startups | Nevele-based early-stage investor biotope by VIB has secured €5 million in the first close of its second fund: Biotope Ventures 2, marking a major step toward its €9 million target over the next 18 months to enable biotope to invest €250k i... |
| 16.06.2025 | Biotope Ventures 2 launches with €5M first close | Biotope Incubator by VIB has secured €5 million in the first close of its second fund, marking a major step toward its €9 million target over the next 18 months.
The fund will enable biotope to invest €250,000 in up to 30 international earl... |
| 29.04.2025 | Paulig’s venture arm PINC invests in the Belgian startup Rainbow Crops to develop climate-resilient crop varieties | Paulig’s venture arm PINC invests in the Belgian startup Rainbow Crops to develop climate-resilient crop varieties
Tue, Apr 29, 2025 07:00 CET Report this content
Rainbow Crops is an agtech company using an AI-powered technology platform th... |
| 29.04.2025 | Qbic III provides pre-seed funding to Rainbow Crops | Ghent, Belgium, 29 April 2025 – VIB proudly announces the launch of its latest spin-off, Rainbow Crops, a next-generation Agtech company focused on engineering complex, high-value agronomic traits that have long been difficult to address. T... |
| 22.10.2024 | Nuclera: Biotech Company Raises $75 Million For Accelerating Protein Expression | Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, announced it had completed a $75 million financing round (circa £57 million). The funding round was led by El... |
| 17.10.2024 | Nuclera's $75 Million Leap: A New Era for Protein Discovery | In the world of biotechnology, speed is everything. Nuclera, a Cambridge-based biotech company, has just secured a $75 million Series C funding round. This significant investment is a game-changer, pushing the boundaries of protein discover... |
| 17.10.2024 | Regulatory bottleneck is thwarting biologicals, says Biotalys CEO: ‘We’ve got to figure out another way’ | “Put it this way,” says Kevin Helash, CEO at Belgium-based ag biologicals firm Biotalys, “If you’re trying to fund an eight-year regulatory process with investors who have a window of five years, there’s a disconnect there.
“I see one of tw... |
| 16.10.2024 | Nuclera raises $75M Series C for eProtein discovery system | Biotech Nuclera has raised a $75 million Series C financing round. This brings the company’s funding to over $140 million.
The company is accelerating protein expression and purification workflows through its benchtop protein system, eProte... |
| 25.09.2024 | Tanai Therapeutics secures additional financing from Novo Nordisk and BioGeneration Ventures for novel obesity drug | Ghent, Belgium, 19 September 2024 – Tanai Therapeutics (“the Company” or “Tanai”), a VIB spin-off company developing a new therapeutic class of obesity treatments, today announces it has secured additional financing from Novo Nordisk A/S an... |
| 23.09.2024 | Biotope Unveils Fifth Cohort Focused on Solutions for Leather, Food Waste, and Natural Colors | Biotope, a Belgian biotech incubator and early-stage investor, has revealed the three startups selected to be part of its fifth and latest cohort: Corium Biotech, I-Challenge, and Lantana Bio.
Launched by the Vlaams Instituut voor Biotechno... |
| 25.07.2024 | Element Biosciences: A New Era in DNA Sequencing**
** | ** Element Biosciences is on a mission. The San Diego-based company is reshaping the landscape of DNA sequencing and multi-omics technology. With a recent infusion of over $277 million in Series D funding, Element is poised to democratize a... |
| 23.07.2024 | Element Biosciences: Over $277 Million In Series D Raised For Democratizing Access To Advanced Biological Tools | Element Biosciences, a developer of pioneering technologies to empower science, announced over $277 million in Series D funding to support its growing global customer base with disruptive DNA sequencing and multi-omics technologies for year... |
| 10.07.2024 | Augustine Therapeutics: €17 Million Raised For Developing Neurodegenerative And Cardiometabolic Disease Treatments | Augustine Therapeutics, a pioneering biotech company focused on novel treatments for neurodegenerative and cardiometabolic diseases, announced that it has raised €17 million in the first closing of its Series A round. This funding round was... |
| 27.05.2024 | French biotech startup Biodol Therapeutics secures €7M to treat chronic pain: Know more | Read this article in:
Montarnaud-based Biodol Therapeutics, a French biotech company developing next-generation pain treatments, announced on Tuesday, May 21, that it has been awarded €7M by BPI France through the i-DEMO call for projects.
... |
| 06.12.2023 | Tanai Therapeutics raises € 2.85 million round in Seed funding | Ghent, 6 December 2023 – VIB, Flanders’ leading life sciences institute, together with lead investor V-Bio Ventures has launched a new spin-off company based on research at the VIB-UGent Center for Inflammation Research. With an initial see... |
| 13.11.2023 | Biotech in Flanders - A Stunning Story: New book reveals the secrets behind the success of the Flemish biotech industry | Cover of the new book 'Biotech in Flanders - A Stunning Story' GHENT, LEUVEN, BELGIUM, November 13, 2023 /EINPresswire.com/ -- Flanders, the northern region of Belgium, is home to one of the most vibrant and innovative life sciences and bio... |
| 13.03.2023 | ExeVir Bio and VIB Announce Data on a New Therapy for Prevention and Treatment for COVID-19. | Ghent, Belgium, 13 March 2023: ExeVir Bio, a biotech company developing robust single domain antibody therapies for broad protection against infectious diseases, and its scientific founders at Belgium’s VIB, Flanders’ leading life sciences ... |
| 14.06.2021 | Montis Biosciences Awarded VLAIO Grant to Expand its Pipeline of Novel Immune-Oncology Therapeutics | Leuven, Belgium, 14 June 2021 -Montis Biosciences, a Belgium-based biotech company focused on the development of novel immuno-oncology therapeutics targeting the interactions between perivascular macrophages and the tumor vasculature, anno... |
| 12.04.2021 | Oncurious NV Reports Encouraging Data from Phase 1 Dose Escalation Study of TB-403 in Paediatric Subjects with Relapsed or Refractory Medulloblastoma Presented at the American Association for Cancer R... | Leuven, Belgium, Boston, MA, US, 12 April 2021 – 7.30 AM CET – ONCURIOUS NV, a Belgium-based biotech company focused on developing innovative oncology treatments, today announces that encouraging data from a Phase 1 dose escalation study of... |
| 09.04.2021 | ONCURIOUS Presenting Clinical and Preclinical Data at Upcoming American Association for Cancer Research (AACR) 2021 Annual Meeting | Oral presentation of Phase 1 dose escalation study of TB-403 in pediatric subjects with relapsed or refractory medulloblastoma (MB)
Poster presentation of research findings of best therapeutic approach to target CCR8 expressed on tumor regu... |
| 24.11.2020 | With companies like Aphea Bio & Biotalys, Ghent is Europe’s hidden gem for ag biotech | The Belgian city of Ghent owes its medieval splendor to being in the middle of the sheep-filled pastureland of Flanders. In centuries past, this provided plentiful supplies of wool – just as breakthrough textiles technologies took off acros... |
| 09.03.2020 | Biotalys increases Series C to €45m to mimic the immunity of certain animals in biological crop protection | Biotalys, a Belgian biotech startup out of Ghent, has raised an extra €10 million ($11.5 million) in Series C funding from new specialist investor Novalis LifeSciences — a New Hampshire based investment and advisory firm for the life scienc... |
| 09.03.2020 | Biotalys increases Series C to $55m to mimic the immunity of certain animals in biological crop protection | Biotalys, a Belgian biotech startup out of Ghent, has raised an extra €10 million ($11.5 million) in Series C funding from new specialist investor Novalis LifeSciences — a New Hampshire based investment and advisory firm for the life scienc... |
| 20.02.2020 | Montis Biosciences launched with â¬8,4 million seed financing and a novel approach to immune-oncology | Montis was founded by Droia Ventures, VIB and KU Leuven based on the foundational science discovered by the labs of Peter Carmeliet (VIB-KU Leuven) and Massimiliano Mazzone (VIB-KU Leuven). For the seed financing, the founders were joined b... |
| 22.01.2019 | Researchers develop multi-color 3D imaging method for living organisms | Scientists from the University of Leuven (KU Leuven), and VIB, a life sciences research institute based in Belgium, have developed a multi-color optical method for 3D imaging surfaces and structures.
The research paper published in the BMC ... |
| 07.09.2017 | Genohm’s client base continues to grow | |
| 26.06.2017 | Aphea.Bio Raises $10m in Series A and Grant Funding for Microbial Soil Technology | Belgian startup Aphea.Bio has launched into the biopesticides and biostimulants sector with €9 million ($10.07m) in funding from a Series A funding round and a local R&D grant.
The startup spun out of Vlaams Instituut voor Biotechnologi... |
| 09.03.2017 | Belgian Startup Using Llama Antibodies for Biopesticides Increases Series B to $11.6m | AgroSavfe, a Belgian agro-biotech company that is developing a new generation of biopesticides, has increased its Series B financing round to $11.6 million. The bulk of the additional investment was provided by the Paris-based venture capit... |
| 11.01.2013 | AgroSavfe Receives €5M in Funding | AgroSavfe, a Gent, Belgium-based green biotech company, recently received €5m in funding.
Backers included Gimv, which invested €2m via the Gimv-Agri+ Investment Fund, and VIB, Sofi, PMV, QBIC and some other venture capitalists, which inves... |
